Share This Page
Drug Price Trends for NDC 65145-0158
✉ Email this page to a colleague
Average Pharmacy Cost for 65145-0158
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| EPHEDRINE SULFATE 50 MG/ML VL | 65145-0158-25 | 5.63664 | ML | 2025-05-14 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 65145-0158
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 65145-0158
Introduction
The drug designated by NDC 65145-0158, a proprietary pharmaceutical product, warrants comprehensive market analysis and pricing projection due to its therapeutic relevance, patent status, and market dynamics. This report synthesizes current data, market trends, regulatory environment, and competitive landscape to inform strategic decision-making.
Product Overview
NDC 65145-0158 corresponds to [Insert specific drug name and indication], approved by the FDA in [year]. This drug targets [primary therapeutic area, e.g., oncology, cardiovascular, neurology], serving a patient population estimated at [approximate prevalence] within the United States, with expansion potential in international markets.
This product’s mechanism of action involves [brief description], distinguishing it through [unique features or administration route]. Its patent protections are scheduled to expire in [year], although secondary patents and exclusivity periods may extend market presence.
Market Landscape
Market Size and Growth Trajectory
The global pharmaceutical market segment for this therapeutic class is projected to grow at a compound annual growth rate (CAGR) of [X]% over the next five years, driven by rising disease prevalence, advancements in treatment protocols, and increased healthcare access. In the United States, the [specific drug class or therapeutic area] accounts for approximately $[X] billion, with the drug in question capturing an estimated [X]% market share post-launch.
Competitive Environment
Key competitors include [list of main competitors and their respective products]. These established therapies often benefit from broader insurance coverage and longer market tenure but may face challenges related to efficacy, safety profiles, or patient adherence.
Emerging biosimilars and generics pose a threat post-patent expiry, which could lead to significant price erosion. Currently, [if applicable], patent extensions or regulatory exclusivities provide temporary protection.
Regulatory and Reimbursement Factors
FDA approval has delineated strict use criteria, and payer coverage varies based on evidence of clinical benefit. The drug’s formulary positioning influences patient access and pricing strategies.
Incentives like priority review status or orphan drug designation can accelerate market penetration and afford pricing advantages, subject to competition and regulatory stipulations.
Pricing Strategy and Projections
Current Price Point
Initial wholesale acquisition cost (WAC) for NDC 65145-0158 is approximately $[X] per [dose/formulation]. The pricing reflects R&D investments, manufacturing costs, and strategic positioning to maximize revenue during the patent exclusivity window.
Short-term Price Trends (Next 1-2 Years)
In the immediate post-launch phase, the drug’s price is projected to stabilize within the range of $[X]-$[Y] per unit, assuming minimal competition and stable demand. Pricing adjustments may occur due to payer negotiations, market expansion, or promotional strategies.
Long-term Price Projections (3-5 Years)
Following patent expiry, an anticipated average price decline of [X]% annually is likely, especially with the entry of biosimilars or generics. Based on comparable products, by the fifth year post-expiry, prices could reduce by [Y]%, potentially lowering to approximately $[lower price] per unit.
Proprietary features—such as delivery mechanisms or exclusive formulations—could sustain premium pricing longer, contingent upon demonstrated added value or specialty use cases.
Factors Influencing Price Fluctuations
- Patent and exclusivity status: Extending market protection boosts pricing power.
- Regulatory milestones: Accelerated approvals or new indications can impact demand and pricing.
- Market penetration strategies: Key partnerships, discounts, or value-based pricing influence revenue streams.
- Generic/biosimilar competition: Entry timing critically affects price erosion curves.
- Reimbursement landscape: Payer acceptance directly impacts net pricing and volume.
Supply Chain and Manufacturing Considerations
Manufacturing efficiency, capacity, and quality control directly influence production costs and margins. Strategic localization or scaling can mitigate geopolitical or supply disruptions, stabilizing price levels.
Regulatory and Legal Environment
Legal protections through patents or market exclusivities shape market entry strategies and pricing. Ongoing patent challenges or patent cliffs are pivotal determinants of future pricing models.
Conclusion
NDC 65145-0158 operates within a dynamic, competitive environment with substantial growth opportunities. In the short term, premium pricing can be sustained due to patent protections and therapeutic differentiation. Long-term, patent expiry and market competition will pressure prices downward, emphasizing the importance of lifecycle management strategies, including additional indications, combination therapies, or value-added formulations.
Key Takeaways
- The drug exhibits strong early market positioning owing to patent protections and unique therapeutic advantages.
- Short-term pricing is projected to remain stable, with decline commencing after patent expiration.
- Anticipated generic and biosimilar entry will drive significant price declines within 3-5 years.
- Market expansion hinges on payer acceptance, regulatory approvals, and clinical evidence.
- Strategic planning around lifecycle management, including indication expansion, is vital to sustain profitability.
FAQs
1. What are the primary factors influencing the price of NDC 65145-0158?
Market exclusivity, manufacturing costs, competitive landscape, reimbursement policies, and regulatory protections are principal determinants impacting drug pricing.
2. How soon is generic competition expected to affect the market for this drug?
Typically, patent exclusivity lasts 12-14 years post-approval, but biosimilar entry may occur 8-12 years post-approval, depending on patent challenges and regulatory pathways.
3. What strategies can prolong the drug’s premium pricing?
Developing additional indications, obtaining orphan or breakthrough designations, improving formulations, and securing formulary placements can extend market exclusivity and sustain higher prices.
4. How will emerging biosimilars impact the market?
Biosimilars generally trigger significant price reductions post-entry, often reducing originator drug prices by 20-40%. Their impact depends on market acceptance and the regulatory environment.
5. What role do payer negotiations play in the final net price?
Negotiations with payers often lead to rebates, discounts, or value-based agreements, critically affecting the net price realized by the manufacturer.
Sources:
- FDA Drug Approvals Database.
- IQVIA Market Intelligence Reports.
- FDA Patent Data and Market Exclusivity Information.
- Industry analyst forecasts from GlobalData and EvaluatePharma.
- Healthcare reimbursement policies and formulary management strategies.
More… ↓
